We have also shown that targeting the c-Met/FRA1/HEY1 cascade mediated by HGF could be a promising treatment strategy for hepatocellular carcinoma (HCC) since the tumor-initiating cells of the liver are regulated by CAFs together with HGF secretions [33]. This evidence concerns the gene HGF and hepatocellular carcinoma.